Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection.

Por Hayden, F G, Andries, K, Janssen, P A
Publicado em 1992

Discrepancy between infectivity and antigenicity stabilization of oral poliovirus vaccine by a capsid-binding compound.

Por Andries, K, Rombaut, B, Dewindt, B, Boeyé, A
Publicado em 1994

Thermal inactivation of oral polio vaccine: contribution of RNA and protein inactivation.

Por Rombaut, B, Verheyden, B, Andries, K, Boeyé, A
Publicado em 1994

In Vitro Interactions between New Antitubercular Drug Candidates SQ109 and TMC207

Por Reddy, Venkata M., Einck, Leo, Andries, K., Nacy, Carol A.
Publicado em 2010

Rates and Mechanisms of Resistance Development in Mycobacterium tuberculosis to a Novel Diarylquinoline ATP Synthase Inhibitor

Por Huitric, E., Verhasselt, P., Koul, A., Andries, K., Hoffner, S., Andersson, D. I.
Publicado em 2010

Synergistic Activity of R207910 Combined with Pyrazinamide against Murine Tuberculosis

Por Ibrahim, M., Andries, K., Lounis, N., Chauffour, A., Truffot-Pernot, C., Jarlier, V., Veziris, N.
Publicado em 2007

An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-[4,5,1-jk] [1,4]benzodiazepin-2 (1H)-one and -thione derivatives.

Por Debyser, Z, Pauwels, R, Andries, K, Desmyter, J, Kukla, M, Janssen, P A, De Clercq, E
Publicado em 1991

Study of the parameters of binding of R 61837 to human rhinovirus 9 and immunobiochemical evidence of capsid-stabilizing activity of the compound.

Por Moeremans, M, De Raeymaeker, M, Daneels, G, De Brabander, M, Aerts, F, Janssen, C, Andries, K
Publicado em 1992

In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity.

Por Andries, K, Dewindt, B, Snoeks, J, Willebrords, R, van Eemeren, K, Stokbroekx, R, Janssen, P A
Publicado em 1992

Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity.

Por Andries, K, Dewindt, B, Snoeks, J, Wouters, L, Moereels, H, Lewi, P J, Janssen, P A
Publicado em 1990

Intranasal pirodavir (R77,975) treatment of rhinovirus colds.

Por Hayden, F G, Hipskind, G J, Woerner, D H, Eisen, G F, Janssens, M, Janssen, P A, Andries, K
Publicado em 1995

Multivariate analysis of human immunodeficiency virus type 1 neutralization data.

Por Nyambi, P N, Nkengasong, J, Lewi, P, Andries, K, Janssens, W, Fransen, K, Heyndrickx, L, Piot, P, van der Groen, G
Publicado em 1996

Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837).

Por al-Nakib, W, Higgins, P G, Barrow, G I, Tyrrell, D A, Andries, K, Vanden Bussche, G, Taylor, N, Janssen, P A
Publicado em 1989

Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase.

Por Pauwels, R, Andries, K, Debyser, Z, Van Daele, P, Schols, D, Stoffels, P, De Vreese, K, Woestenborghs, R, Vandamme, A M, Janssen, C G
Publicado em 1993

New tetrahydroimidazo[4,5,1-jk][1,4]-benzodiazepin-2(1H)-one and -thione derivatives are potent inhibitors of human immunodeficiency virus type 1 replication and are synergistic wi...

Por Pauwels, R, Andries, K, Debyser, Z, Kukla, M J, Schols, D, Breslin, H J, Woestenborghs, R, Desmyter, J, Janssen, M A, De Clercq, E
Publicado em 1994

Study of the dynamics of neutralization escape mutants in a chimpanzee naturally infected with the simian immunodeficiency virus SIVcpz-ant.

Por Nyambi, P N, Lewi, P, Peeters, M, Janssens, W, Heyndrickx, L, Fransen, K, Andries, K, Vanden Haesevelde, M, Heeney, J, Piot, P, van der Groen, G
Publicado em 1997

Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir

Por Bantia, S., Parker, C. D., Ananth, S. L., Horn, L. L., Andries, K., Chand, P., Kotian, P. L., Dehghani, A., El-Kattan, Y., Lin, T., Hutchison, T. L., Montgomery, J. A., Kellog, D. L., Babu, Y. S.
Publicado em 2001

Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resis...

Por Diacon, A. H., Donald, P. R., Pym, A., Grobusch, M., Patientia, R. F., Mahanyele, R., Bantubani, N., Narasimooloo, R., De Marez, T., van Heeswijk, R., Lounis, N., Meyvisch, P., Andries, K., McNeeley, D. F.
Publicado em 2012